Physician profile
Robert P Penney
NPI 1790773653
$18,551.18
in general payments reported to CMS, 2019-2025
34 companies · $241 in 2025
The $241 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $719 · 2020: $103 · 2021: $17K · 2022: $193 · 2023: $177 · 2024: $101 · 2025: $241.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $433 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $433.49 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $16,998.89 | 2019-2023 | Da Vinci Surgical System |
| Astellas Pharma US INC | $210.48 | 2019-2025 | Veozah, Myrbetriq |
| Medtronic USA, INC. | $117.49 | 2019 | |
| Abbvie INC. | $93.70 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $91.38 | 2022-2025 | |
| Dysis Medical, INC. | $78.65 | 2021-2022 | |
| Vertical Pharmaceuticals, LLC | $72.96 | 2019 | |
| Hologic Sales and Service, LLC | $71.16 | 2021-2025 | Acessa Provu System, Coolseal Generator, Novasure |
| Bayer Healthcare Pharmaceuticals INC. | $65.35 | 2019-2025 | |
| Davol INC. | $57.32 | 2021 | |
| Pfizer INC. | $56.99 | 2019-2023 | |
| Coopersurgical, INC. | $53.56 | 2021-2024 | Paragard T 380a |
| Amag Pharmaceuticals, INC. | $53.37 | 2019 | |
| Daiichi Sankyo INC. | $50.84 | 2019-2022 | |
| Scynexis, INC. | $48.74 | 2021-2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $47.79 | 2019-2020 | |
| Aspira Women'S Health INC | $45.44 | 2019-2025 | Ova1 |
| Evofem Biosciences, INC. | $31.73 | 2021-2024 | |
| Therapeuticsmd, INC. | $29.96 | 2021 | |
| Gynesonics, INC. | $29.38 | 2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Exeltis, USA INC. | $27.14 | 2019-2022 | |
| Duchesnay USA Incorporated | $26.56 | 2019 | |
| Agile Therapeutics, INC. | $25.62 | 2021 | |
| Alydia Health | $24.00 | 2021 | |
| Meditrina | $22.15 | 2025 | |
| Myovant Sciences INC. | $18.14 | 2022 | |
| Sumitomo Pharma America, INC. | $15.27 | 2024 | Myfembree |
| Sage Therapeutics, LLC | $14.77 | 2024 | |
| Medicem INC. | $14.64 | 2021 | |
| Merck Sharp & Dohme LLC | $12.84 | 2021 | |
| Allergan, INC. | $12.50 | 2019 | |
| Millicent US INC | $11.43 | 2019 | |
| Organon LLC | $11.22 | 2025 | Nexplanon |
| Channel Medsystems, INC. | $9.72 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Penney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.